Global professional diagnostics market forecast

According to the professional diagnostics market analysis, the global professional diagnostics market is projected to witness impressive growth at a CAGR of close to 7% over the forecast period. The increasing focus on diagnosing life-threatening conditions, such as sepsis and acute cardiac infarction, boosts the point of care testing (POCT) segment, which, in turn, will drive the professional diagnostics market growth. To avoid the complications associated with clinical trials, the manufacturers have developed POCT for nucleic acid extraction, amplification, and detection. Moreover, POCTs use miniaturized microfluidics systems that are quite inexpensive and deliver results in a few hours. Also, POCT equipment is portable, and its capillary tubes need lesser amounts of reagents. Some of the examples of POCT systems used extensively are MinION900 by Oxford Nanopore Technologies, which costs around USD 900 and GeneXpert Omn by Cephid. The low cost and portability features of such POCT equipment will lead to their increased adoption across the globe.

In terms of geography, the Americas accounted for the maximum market share during 2015 and will continue to dominate the market in the coming years. The US has the biggest market share for the sales of professional diagnostics in the region. The growth of this market in the Americas is attributed to the growing elderly population and the high prevalence of chronic and infectious diseases. Also, the increasing awareness among the population has compelled most people across the US and Canada to opt for regular tests and check-ups. This increase in the preference for regular tests and check-ups has increased the sales of professional diagnostics products in the region. Other factors such as growing laboratory automation, the shift toward molecular diagnostic tests, and the increasing FDA approval of new products are also expected to aid in this market’s growth in the Americas in the near future.

Competitive landscape and key vendors

The global professional diagnostics market is highly fragmented because of the presence of several well-established large and small vendors. To improve their market position, larger vendors partner with other vendors to come up with better-performing products. For instance, Roche Diagnostics and Foundation Medicine partnered with each other to strengthen the progress of personalized treatment for people with cancer. Vendors are also entering into strategic agreements to develop and market test strips and blood glucose meters.

Key vendors in this market are 

• Abbott Diagnostics
• Danaher
• Roche Diagnostics
• Siemens Healthcare
• Thermo Fisher Scientific

Other prominent vendors in the market include A&T, A. Menarini Diagnostics, Abaxis, Abcam, Accriva Diagnostics, Acon Laboratories, Affymetrix, Ahram Biosystem, ARKRAY, AsuraGen, Biocartis, Bio-Rad Laboratories, CellaVision, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, Corgenix, DiagCor, Drucker Diagnostics, EKF Molecular Diagnostics, Erba Diagnostics, GREEN CROSS MEDIS, Helena Laboratories, Hologic, HORIBA, Instrumentation Laboratory, i-Sens, Landwind Medical, Mindray, Nihon Kohden, Nipro Diagnostics, Randox Laboratories, Sekisui Medical, Sienco, Sinduri Biotec, Snibe Diagnostics, Stago, and Trivitron Healthcare.

Product segmentation and analysis of the professional diagnostics market

• Immunochemistry
• Clinical microbiology
• POCT
• Hematology
• Hemostasis

During 2015, the immunochemistry segment was the highest revenue generating product segment in the professional diagnostics market. There are high chances of growth for affordable immunochemistry analyzers since rural hospitals in regions such as India and China require basic diagnostics laboratory infrastructure. Also, vendors are coming up with innovative products to facilitate the early detection of fatal diseases, such as HIV, which will also aid in this market segment’s growth.

Segmentation by end user and analysis of the professional diagnostics market

• Hospitals
• Diagnostic laboratories

The hospital sector accounted for the majority of revenue market shares during 2015 and will dominate the market during the predicted period. Most people prefer hospitals over diagnostic laboratories, making hospitals the largest end user for professional diagnostics. They do so because it is considered as an integral part of disease diagnosis, treatment, monitoring response to treatment, disease surveillance programs, and clinical research. The diagnostic techniques are used to ease the overall process of early disease diagnosis and promote wellness. The hospital segment will continue to dominate the market since the laboratories in hospitals are considered to be the best laboratory settings for diagnosis.

Key questions answered in the report include

• What will the market size and the growth rate be in 2020?
• What are the key factors driving the global professional diagnostics market?
• What are the key market trends impacting the growth of the global professional diagnostics market?
• What are the challenges to market growth?
• Who are the key vendors in the global professional diagnostics market?
• What are the market opportunities and threats faced by the vendors in the global professional diagnostics market?
• What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
• What are the key outcomes of the five forces analysis of the global professional diagnostics market?

Technavio also offers customization on reports based on specific client requirement.

Related reports:

• Global Rapid Diagnostics Market 2016-2020
• Global Gonorrhea Diagnostics Market 2016-2020
• Global Dermatology Diagnostic Devices Market 2016-2020
• Global Autoimmune Disease Diagnostics Market 2017-2021